Home Companies Janssen Biotech

Janssen Biotech

Latest

Infectious Diseases

StockWatch: Moderna’s Positive Phase III RSV Vaccine Data Wows Analysts

Immunology

StockWatch: Horizon Soars on Talks with Amgen, J&J, Sanofi

Conceptual illustration of neuron cells with glowing link knots. Synapse and neuron cells sending electrical chemical signals. Neuron of Interconnected neurons with electrical pulses, 3D illustration

Alzheimers

Jabbing at Alzheimer’s: AC Immune Takes Precision Approach to Vaccines

Musculoskeletal Disorders

Same Drug, New Partner: Capricor in Up-to-$735M Deal for DMD Cell Therapy

Janssen Biotech

FDA, CDC Urge Pause in J&J COVID-19 Vaccination, Citing “Rare” Blood Clots

Janssen Biotech

J&J Seeks EUA for COVID-19 Vaccine

Janssen Biotech

J&J Reports 66% Overall Efficacy for One-Dose COVID-19 Vaccine

Janssen Biotech

J&J’s Janssen Launches Up-to-60,000-Patient Phase III Trial for COVID-19 Vaccine

Janssen Biotech

As Pressure Mounts, CEOs Commit to Science, Safety in Developing COVID-19...

Janssen Biotech

J&J’s Janssen Speeds Up Planned Launch of COVID-19 Vaccine Trial

Janssen Biotech

J&J’s Janssen, Fate Therapeutics Launch Up-to-$3B Cancer Immunotherapy Collaboration

Janssen Biotech

J&J Eyes September Trial for COVID-19 Vaccine, Commits to Expanded $1B+...

Janssen Biotech

Janssen, Genmab Partner on Follow-On to Darzalex for Multiple Myeloma, Diffuse...

Janssen Biotech

Genmab Files for $500M U.S. IPO, Seeking to Launch a Proprietary...

Janssen Biotech

JLABS, Children’s National to Open Incubator, Collaborate on BARDA “Innovation Zone”...

12 3 Page 1 of 3